Valganciclovir prophylaxis for cytomegalovirus disease in kidney and simultaneous pancreas-kidney transplant recipients.

被引：0
|
作者：
Ciancio, G
Burke, G
Suzart, K
Vaidya, A
Roth, D
Kupin, W
Mattiazzi, A
Miller, J
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：371 / 371
页数：1
相关论文
共 50 条
  • [31] BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients
    Westphal, Scott G.
    Lyden, Elizabeth R.
    Langewisch, Eric D.
    Miles, Clifford D.
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [32] The Cardinal Features of Recurrent Autoimmunity in Simultaneous Pancreas-Kidney Transplant Recipients
    Boaz Hirshberg
    Current Diabetes Reports, 2010, 10 : 321 - 322
  • [33] Tertiary Hyperparathyroidism in Simultaneous Pancreas-Kidney Transplant Recipients: a Retrospective Analysis
    Cavey, Lane
    Foster, Erin
    Patel, Ruchin
    Ibrahim, Mohamed
    Whitlatch, Hilary
    Meier, Raphael
    Alvarez-Casas, Josue
    Bromberg, Jonathan
    Niederhaus, Silke
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S62 - S62
  • [34] The effect of pretransplant blood transfusions in recipients of a simultaneous pancreas-kidney transplant
    Waanders, M. M.
    Roelen, D. L.
    de Fijter, J. W.
    Mallat, M. J.
    Doxiadis, I. I. N.
    Brand, A.
    Claas, F. H. J.
    TISSUE ANTIGENS, 2007, 69 (05): : 497 - 497
  • [35] Standard-versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients.
    Wilson, N.
    Sulejmani, N.
    Jantz, A.
    Patel, A.
    Summers, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 532 - 532
  • [36] Changes in the clinical characteristics of post transplant lymphoproliferative disease (PTLD) in kidney and simultaneous pancreas-kidney recipients (SPK).
    Pelletier, RP
    Davies, EA
    Henry, ML
    Elkhammas, EA
    Bumgardner, GL
    Ferguson, RM
    TRANSPLANTATION, 1999, 67 (09) : S621 - S621
  • [37] Insulin secretory capacity and sensitivity estimated by CIGMA in pancreas-kidney transplant recipients.
    Smets, Y
    Pijl, J
    Frolich, M
    Ringers, J
    DeFijter, J
    Lemkes, H
    DIABETES, 1997, 46 : 1104 - 1104
  • [38] Expanded valganciclovir prophylaxis in kidney transplant recipients is associated with lower incidence of cytomegalovirus infection
    Veceric-Haler, Zeljka
    Bizjak, Bostjan
    Romozi, Karmen
    Arnol, Miha
    CLINICAL NEPHROLOGY, 2017, 88 : S126 - S130
  • [39] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis
    Liang, Xinyun
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    PROGRESS IN TRANSPLANTATION, 2018, 28 (02) : 124 - 133
  • [40] EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION
    Bizjak, Bostjan
    Veceric-Haler, Zeljka
    Romozi, Karmen
    Arnol, Miha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 407 - 407
12345